Americann Inc (ACAN) is a publicly traded real estate services business based in the US. On 20 September AmeriCann shares leapt 8.82% to a closing position of $0.338. Over the last 12 months, AmeriCann's share price has risen by 37.50% from $0.8. AmeriCann is listed on the OTCQB and employs 3 staff. All prices are listed in US Dollars.
Best for
0% commission
Best for
Beginner investments
Best for
Mobile app
Best for
Referral bonus
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | $10 | £0.99 £198.13 total |
Capital at risk |
|
£0 | £250 | £9.99 £207.13 total |
Capital at risk |
|
£0 | No minimum | £1.97 £199.11 total |
Capital at risk |
 |
£0 | £1 | £13.92 £211.06 total |
Capital at risk |
 |
£0 | £0.01 | £0.20 £197.34 total |
Capital at risk |
 |
£9.99 per month | No minimum | £10.95 £208.09 total |
Capital at risk |
 |
£0 | £50 | £0.99 £198.13 total |
Capital at risk |
 |
£36 per year | £20 | £11.96 £209.11 total |
Capital at risk |
Full comparison of share dealing platforms
Historical closes compared with the last close of $1.1
| 1 week (2022-09-22) | 243.75% |
|---|---|
| 1 month (2022-08-29) | 165.70% |
| 3 months (2022-06-29) | 208.99% |
| 6 months (2022-03-28) | 155.52% |
| 1 year (2021-09-27) | 29.02% |
|---|---|
| 2 years (2020-09-29) | 139.13% |
| 3 years (2019-09-27) | 18.28% |
| 5 years (2017-09-29) | -42.11% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
AmeriCann's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $850,625 (£762,245).
The EBITDA is a measure of a AmeriCann's overall financial performance and is widely used to measure a its profitability.
| Open | $1.09 |
|---|---|
| High | $1.1 |
| Low | $1.08 |
| Close | $1.1 |
| Previous close | $1.07 |
| Change | $0.03 |
| Change % | 2.8037% |
| Volume | 6,577 |
| 52-week range | $0.3 - $0.888 |
|---|---|
| 50-day moving average | $0.3646 |
| 200-day moving average | $0.4434 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.03 |
We're not expecting AmeriCann to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, AmeriCann's shares have ranged in value from as little as $0.3 up to $0.888. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while AmeriCann's is 1.1091. This would suggest that AmeriCann's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to buy shares in Veru? We explain how and compare a range of providers that can give you access to many brands, including Veru.
Ever wondered how to buy shares in C4 Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including C4 Therapeutics.
Ever wondered how to buy shares in Clever Leaves? We explain how and compare a range of providers that can give you access to many brands, including Clever Leaves.
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
Ever wondered how to buy shares in Bone Biologics? We explain how and compare a range of providers that can give you access to many brands, including Bone Biologics.
Ever wondered how to buy shares in Adagio Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Adagio.
Ever wondered how to buy shares in Bolt Biotherapeutics? We explain how and compare a range of providers that can give you access to many brands, including Bolt Biotherapeutics.
Ever wondered how to buy shares in Vallon Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Vallon Pharmaceuticals.
Ever wondered how to buy shares in Qualigen Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Qualigen.